Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: A 6-month randomized, double- blind, and placebo- controlled trial in equol- producing postmenopausal women
Publication in refereed journal

Times Cited
Web of Science36WOS source URL (as at 02/07/2020) Click here for the latest count
Altmetrics Information

Other information
AbstractScopeEquol is produced by the intestinal bacteria from isoflavone daidzein. Studies have reported the health benefits of soy can only present or more pronounced in equol producers. This 6-month randomized controlled trial examined the effect of whole soy (soy flour) and purified daidzein on cardiovascular biomarkers and carotid intima-media thickness (CIMT) in prehypertensive postmenopausal women who were equol producers.
All Author(s) ListLiu ZM, Ho SC, Chen YM, Ho S, To K, Tomlinson B, Woo J
Journal nameMolecular Nutrition and Food Research
Volume Number58
Issue Number4
Pages709 - 717
LanguagesEnglish-United Kingdom
KeywordsCardiovascular risks; Daidzein; Inflammatory marker; Lipids; Whole soy
Web of Science Subject CategoriesFood Science & Technology; FOOD SCIENCE & TECHNOLOGY

Last updated on 2020-03-07 at 00:50